@article {Pastor70, author = {Charles A. Pastor and Monica Mehta}, title = {Masked Clozapine-induced Cardiomyopathy}, volume = {21}, number = {1}, pages = {70--74}, year = {2008}, doi = {10.3122/jabfm.2008.01.070091}, publisher = {The Journal of the American Board of Family Medicine}, abstract = {A 33-year-old Latin-American woman with a history of psychosis and mood disorder, but no cardiac history or risk factors, presented with heart failure after 6 weeks of clozapine and olanzapine therapy. Her presentation was ambiguous and further complicated by a highly suggestible nature, which delayed the proper diagnosis and treatment. After discontinuing the antipsychotic agents and completing an otherwise negative comprehensive work-up, her heart function significantly improved (left ventricular ejection fraction increased from 38\% to 53\%). A literature search showed that cardiomyopathy secondary to antipsychotics has been reported but remains poorly understood. This is the second documented case report of clozapine-induced cardiomyopathy in a Latin-American woman.}, issn = {1557-2625}, URL = {https://www.jabfm.org/content/21/1/70}, eprint = {https://www.jabfm.org/content/21/1/70.full.pdf}, journal = {The Journal of the American Board of Family Medicine} }